Trial of Psilocybin versus Escitalopram for Depression
2021 · New England Journal of Medicine · 1,297 citations
https://doi.org/10.1056/nejmoa2032994
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
1.5K
Citations
3
h-index
3
i10-index
Michelle Baker-Jones is an academic researcher from Imperial College London. The author has contributed to research in topics: Neurotransmitter Receptor Influence on Behavior & Psychedelics and Drug Studies & Chemical synthesis and alkaloids. The author has an h-index of 3, co-authored 4 publications.
https://doi.org/10.1056/nejmoa2032994
https://doi.org/10.1017/s0033291723001514
Click to start Chat